Binsheng Zhao, DSc
Overview
Academic Appointments
- Professor of Radiology (Physics) at CUMC
Administrative Titles
- Director for Computational Image Analysis Laboratory
Binsheng Zhao is a Professor of Radiology (Physics) and the Director of the Laboratory for Computational Image Analysis in the Department of Radiology, CUMC. She received her BS and MS degrees both in electronic engineering from National Institute of Technology at Changsha, China, and her DSc degree in medical informatics from University of Heidelberg, Germany.
Research Areas:
Computer-aided cancer detection and diagnosis; tumor, organ and tissue segmentation; quantitative imaging biomarkers / radiomics for response prediction and assessment in oncology and neurologic diseases; reproducibility of quantitative imaging features; optimized workflow in response assessment . Lab Web Site
Languages
- German
- Chinese
Gender
- Female
Credentials & Experience
Education & Training
- BS, Electrical Engineering, National Institute of Technology at Changsha
- MS, Electrical Engineering, National Institute of Technology at Changsha
- DSc, Medical Informatics, University of Heidelberg
Honors & Awards
- 1991: Gottlieb Daimler-Karl Benz Foundation Fellowship, Ladenburg, Germany
- 1997: President's Council of Cornell Women Award, Ithaca, New York
- 2014: Award for Recognition of Outstanding Contribution, Radiological Society of North America (RSNA) / Quantitative Imaging Biomarkers Alliance (QIBA)
Research
Grants
SERVICE AGREEMENT (P&S Industry Clinical Trial)
Jan 18 2019 - Jan 18 2024
INTEGRATING RADIOMICS INTO S0819 AND LUNG-MAP, BIOMARKER DRIVEN CLINICAL TRIALS FOR LUNG CANCER (Federal Gov)
Jun 1 2018 - May 31 2023
QUANTITATIVE IMAGING TOOLS TO DERIVE DW-MRI ONCOLOGICAL BIOMARKERS (Federal Gov)
Jul 1 2017 - Jun 30 2022
A PROSPECTIVE, RANDOMIZED STUDY TO COMPARE EFFECTS OF ULIPIRISTAL ACETATE WITH A COMBINED ORAL CONTRACEPTIVE ON BREAST EPITHELIAL CELL PROLIFERATION (Federal Gov)
Jun 17 2016 - Jun 30 2020
COMPUTATIONAL MODELING OF TUMOR BURDEN BY CT TO ADVANCE CANCER THERAPEUTICS (Federal Gov)
Apr 1 2017 - Mar 31 2019
SERVICE AGREEMENT-GO28651 (P&S Industry Clinical Trial)
Sep 30 2013 - Sep 30 2018
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TEPOTECAN FOR GLIOBLASTOMA (Federal Gov)
Jul 1 2012 - Apr 30 2018
STUDYING MEASUREMENT VARIABILITY IN TUMOR VOLUME AND VOLUME CHANGE ON MDCT (Federal Gov)
Apr 1 2011 - Mar 31 2018
VOL-PACT: VOLUMETRIC CT, IMPROVING METRICS FOR PHASE II ANALYSIS OF CLINICAL TRIAL RESULTS (Private)
Jan 21 2015 - Jan 20 2018
QUANTITATIVE VOLUME AND DENSITY RESPONSE ASSESSMENT SARCOMA AND HCC AS A MODEL (Federal Gov)
Sep 1 2011 - Aug 31 2017
AUTOMATED SOFTWARE FOR GLIOMA TREATMENT RESPONSE MONITORING USING MRI (Private)
Jul 1 2015 - Jun 30 2017
INFORMATICS TOOLS FOR OPTIMIZED IMAGING BIOMARKERS FOR CANCER RESEARCH & DISCOVERY (Federal Gov)
Sep 1 2014 - Aug 31 2016
COMPUTATIONAL MODELING OF TUMOR BURDEN BY CT TO ADVANCE CANCER THERAPEUTICS (Federal Gov)
Apr 22 2015 - Mar 31 2016
PHASE II CLINICAL TRIAL OF PERIFOSINE + TEMSIROLIMUS FOR RECURRENT GLIOBLASTOMA WITH TISSUE AND IMAGING CORRELATES OF RESPONSE (Private)
Jan 1 2013 - Dec 31 2015
PHANTOMS FOR CT VOLUMETRY OF HEPATIC AND NODAL METASTASIS (Federal Gov)
Sep 30 2013 - Sep 29 2015
ADVANCED ANATOMIC AND FUNCTINAL RESPONSE ASSESSMENT IN LUNG CANCER (Federal Gov)
Aug 7 2007 - Jun 30 2014
CANCER AND LEUKEMIA GROUP B FOUNDATION COMMITTEE ACTIVITIES (Private)
Jan 1 2009 - Dec 31 2013